HNC-1399

N/A

Report date: 2022/12/07 13:49:04
NME

Base Information

Drug NameHNC-1399
Drug Alias NameHNC-1399
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor-interacting serine/threonine-protein kinase 1 inhibitors
TargetsReceptor-interacting serine/threonine-protein kinase 1
Therapy Area/IndicationsLung Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangzhou Henovcom Bioscience Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGuangzhou Henovcom Bioscience Co Ltd
Inactive CompaniesN/A
Active IndicationsLung Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A